Important information

A person with a suspected urogenital cancer should be referred to a urologist who is a member of a urogenital (or similar) multidisciplinary team.

All specialists listed on Canrefer are members of a multidisciplinary team.

What is urogenital cancer?

Urogenital cancer is cancer that starts in the cells of the urinary tract which includes the bladder and kidneys. Urogenital cancers of the prostate, testes (testicles) and penis occur in men.

For information on specialist centres for bladder cancer, visit the bladder cancer page. For more information on prostate cancer, see the prostate cancer page. 

 

What tests are needed for urogenital cancer?

Common tests used to diagnose a urogenital cancer include:

  • physical examination
  • blood tests
  • imaging - ultrasound, CT scan and/or MRI scan
  • biopsy.

 

What treatment options are there for urogenital cancer?

Treatment for urogenital cancer may include one or more of the following:

  • surgery
  • chemotherapy
  • targeted therapy
  • radiotherapy.

If treatment is specialised and complex, patients may need to travel to have a part of their treatment. The local health district will have an arrangement in place for this.

 

How common is urogenital cancer in NSW?

Urogenital cancer was diagnosed in:

  • 2014
    8795 people in NSW
  • 2013
    9197 people in NSW
  • 2012
    9721 people in NSW

Data source: Annual NSW cancer incidence and mortality dataset, 2014 (sourced from the NSW Cancer Registry)


Last updated: 17 October 2018